$275 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 8 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NTP | Sell | NAM TAI PPTY INC | $142,141,000 | +118.1% | 5,129,590 | -2.9% | 51.61% | +68.0% |
| CDMO | AVID BIOSERVICES INC | $60,200,000 | +40.7% | 2,346,961 | 0.0% | 21.86% | +8.4% | |
| Sell | DERMTECH INC | $45,322,000 | -51.0% | 1,090,254 | -40.2% | 16.46% | -62.3% | |
| XPEL | XPEL INC | $8,711,000 | +61.5% | 103,860 | 0.0% | 3.16% | +24.4% | |
| ATEX | New | ANTERIX INC | $7,577,000 | – | 126,311 | +100.0% | 2.75% | – |
| NOTV | Sell | INOTIV INC | $7,120,000 | +13.6% | 266,880 | -14.9% | 2.58% | -12.5% |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $4,213,000 | – | 93,883 | +100.0% | 1.53% | – |
| CHS | New | CHICOS FAS INC | $136,000 | – | 20,690 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NAM TAI PPTY INC | 16 | Q3 2022 | 60.5% |
| AVID BIOSERVICES INC | 13 | Q4 2021 | 46.6% |
| XPEL INC | 10 | Q4 2021 | 22.3% |
| TARO PHARMACEUTICALS INDUS LTD | 8 | Q4 2015 | 85.7% |
| AMERCO | 8 | Q4 2015 | 11.2% |
| NATHANS FAMOUS INC NEW | 7 | Q1 2017 | 68.9% |
| MMA CAP MGMT LLC | 7 | Q1 2017 | 17.8% |
| CBL & ASSOC PPTYS INC | 6 | Q3 2023 | 95.2% |
| LIFECORE BIOMEDICAL INC | 6 | Q4 2022 | 35.1% |
| CRYO-CELL INTL INC | 6 | Q4 2022 | 11.0% |
View ISZO CAPITAL MANAGEMENT LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
View ISZO CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.